Xu Li

The University of Texas Southwestern Medical Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “YAP antagonizes TEAD‐mediated AR signaling and prostate cancer growth”.

YAP antagonizes TEAD‐mediated AR signaling and prostate cancer growth

The EMBO Journal(2023)10.15252/embj.2022112184

N/A

1.2DataRank · unranked

41 citations

Shu Zhuo, Yong Suk Cho, Yuchen Liu, Yingzi Yang, Jian Zhu +2 more

YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis

Nature Communications(2022)10.1038/s41467-022-30831-5

N/A

0DataRank · unranked

70 citations

Shu Zhuo, Ting Zhuang, Yong Suk Cho, Guojin Wu, Yuchen Liu +8 more

The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth

Cell Discovery(2022)10.1038/s41421-022-00465-4

N/A

0DataRank · unranked

16 citations

Yong Suk Cho, Jian Zhu, Shu Zhuo, Jin Jiang, Xu Li

The Hippo pathway effector YAP inhibits NF-κB signaling and ccRCC growth by opposing ZHX2

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.108430

N/A

0DataRank · unranked

5 citations

Yong Suk Cho, Yuhong Han, Mengmeng Zhou, Yuchen Liu, Yingzi Yang +3 more